Pfizer/Eisai’s Aricept Becomes First Treatment Approved For All Degrees of Alzheimer’s
This article was originally published in The Pink Sheet Daily
Executive Summary
Because Aricept is often used in combination with Namenda, though, Forest says it is not concerned about market share erosion.
You may also be interested in...
Forest Once-Daily Namenda Positioned To Launch Ahead Of Immediate-Release Generics
Forest outlines top-line Phase III data showing benefit of a once-daily dose for treatment of dementia.
Forest Once-Daily Namenda Positioned To Launch Ahead Of Immediate-Release Generics
Forest outlines top-line Phase III data showing benefit of a once-daily dose for treatment of dementia.
Forest Labs Aims To Launch Once-Daily Namenda Ahead Of Generics
Alzheimer's line-extension is in Phase III, and first ANDA with paragraph IV certification for current twice-daily formula could be filed next fall.